Natamycin in the treatment of chronic recurrent vulvovaginal candidiasis associated with intestinal candidiasis

Abstract

This article discusses the natamycin therapy outcomes in 50 patients with a combination of chronic recurrent vulvovaginal candidiasis (CRVC) and intestinal candidiasis dysbiosis (ICD) and analyses the features of the clinical manifestations of CRVC against the background of the ICD, the species composition and sensitivity patterns of Candida cultures isolated from women with vaginal and intestinal discharge to various antimycotics.

Keywords

• chronic recurrent vulvovaginal candidiasis
• intestinal candidiasis dysbiosis
• fungi of the genus candida
• natamycin